Successful Structure-Based Design of Recent p38 MAP Kinase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 7, 2009-05 ,pp. : 655-676

Bentham Science Publishers

Access to resources Recommend Favorite

The Spleen Tyrosine Kinase (Syk) in Human Disease, Implications for Design of Tyrosine Kinase Inhibitor Based Therapy

By  

Current Pharmaceutical Design, Vol. 10, Iss. 15, 2004-06 ,pp. : 1739-1744

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-based design, discovery and development of checkpoint kinase inhibitors as potential anticancer therapies

By Matthews Thomas P   Jones Alan M   Collins Ian  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 6, 2013-10 ,pp. : 621-640

Informa Healthcare

Access to resources Recommend Favorite

Targeting Mitogen-Activated Protein Kinase Phosphatase-1 (MKP-1): Structure-Based Design of MKP-1 Inhibitors and Upregulators

By  

Current Medicinal Chemistry, Vol. 19, Iss. 2, 2012-01 ,pp. : 163-173

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in the Structure-Based Design of the Influenza A Neuraminidase Inhibitors

By  

Current Drug Targets, Vol. 11, Iss. 3, 2010-03 ,pp. : 315-326

Bentham Science Publishers

Access to resources Recommend Favorite